Exploring the influencing factors of the pathologic complete response in estrogen receptor-positive, HER2-negative breast cancer after neoadjuvant chemotherapy: a retrospective study

BACKGROUND: Pathological complete response (pCR) is the goal of neoadjuvant chemotherapy (NACT). We aimed to develop a nomogram to predict the probability of achieving pCR in estrogen receptor-positive (ER+), HER2-negative (HER2−) breast cancer patients. METHODS: A total of 273 ER+, HER2− breast can...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Lingfeng, Shu, Xiujie, Tu, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800274/
https://www.ncbi.nlm.nih.gov/pubmed/35093083
http://dx.doi.org/10.1186/s12957-022-02492-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800274/
https://www.ncbi.nlm.nih.gov/pubmed/35093083
http://dx.doi.org/10.1186/s12957-022-02492-7

Ejemplares similares